Ostermann, Marlies https://orcid.org/0000-0001-9500-9080
Forni, Lui G. https://orcid.org/0000-0002-0617-5309
Joannidis, Michael https://orcid.org/0000-0002-6996-0881
Kane-Gill, Sandra L. https://orcid.org/0000-0001-7523-4846
Legrand, Matthieu https://orcid.org/0000-0001-9788-5316
Lumlertgul, Nuttha https://orcid.org/0000-0003-1506-4253
McNicholas, Bairbre https://orcid.org/0000-0001-9524-4021
Meersch, Melanie https://orcid.org/0000-0002-6011-8049
Monard, Celine https://orcid.org/0000-0003-2240-0905
Pickkers, Peter https://orcid.org/0000-0002-1104-4303
Prowle, John https://orcid.org/0000-0002-5002-2721
Rimmelé, Thomas https://orcid.org/0000-0001-7578-1073
Schneider, Antoine https://orcid.org/0000-0003-0576-7094
Zarbock, Alexander https://orcid.org/0000-0002-2124-1714
Kellum, John A. https://orcid.org/0000-0003-1995-2653
Article History
Received: 12 May 2025
Accepted: 8 July 2025
First Online: 28 July 2025
Declarations
:
: MO received research funding from Baxter and bioMerieux (paid to institution). LGF received research funding from Baxter, lecture fees from Vantive and SphingoTec and discloses consulting fees from AstraZeneca. MJ has received honoraria or research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius, Takeda and Novartis outside the submitted work. SKG received National Institute of Diabetes and Digestive and Kidney Diseases grant funding and is a Critical Care Speciality Board Member of the American Board of Internal Medicine. JAK is a full-time employee of Spectral Medical and holds stock in the company. He also discloses consulting fees paid by AstraZeneca, Bayer, bioMérieux, Chugai Pharma, Mitsubishi Tenabe, and Novartis. ML has received consulting fees from Viatris, Radiometer, Idorsia and Alexion. MM received lecture fees from Baxter, FMC and Franz-Köhler-Chemie as well as an unrestricted research grant from Baxter. CM received lecture fees from Baxter, Fresenius Medical Care and bioMérieux and a research grant from bioMerieux. JP received honoraria for lectures from Vantive and Nikkisso Europe GmbH. AS received research funding from B Braun Avitum and Jafron Medical, consulting fees from Jafron Medical, and lecture fees from Fresenius Medical Care, B Braun Avitum and Jafron. TR discloses fees for lectures at medical conferences paid by Baxter, Fresenius Medical Care and bioMérieux. AZ received research funding from Baxter and bioMérieux, consulting fees from Baxter, BioMerieux, AM Pharma, Bayer, Novartis, Renibus, Guard Therapeutics, Paion and Viatris, and lecture fees from Baxter and bioMérieux.
: Not applicable.